|
Volumn 264, Issue 5160, 1994, Pages 833-835
|
Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cells
a a a a b a a b c a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CD28 ANTIGEN;
CD3 ANTIGEN;
CD30 ANTIGEN;
MONOCLONAL ANTIBODY;
T LYMPHOCYTE RECEPTOR;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CANCER IMMUNOTHERAPY;
CONTROLLED STUDY;
HODGKIN DISEASE;
HUMAN;
HUMAN CELL;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
T LYMPHOCYTE;
XENOGRAFT;
ANIMALS;
ANTIBODIES, BISPECIFIC;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD28;
ANTIGENS, CD3;
ANTIGENS, CD30;
HODGKIN DISEASE;
HUMANS;
LYMPHOCYTE ACTIVATION;
MICE;
MICE, SCID;
NEOPLASM TRANSPLANTATION;
RECEPTORS, ANTIGEN, T-CELL;
T-LYMPHOCYTE SUBSETS;
TRANSPLANTATION, HETEROLOGOUS;
ANIMALIA;
|
EID: 0028227751
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.8171337 Document Type: Article |
Times cited : (156)
|
References (30)
|